KYTX (Kyverna Therapeutics) Forvard P/E multiplikatori

Kyverna (KYTX) kompaniyasining korporativ logotipi

Kyverna Therapeutics (KYTX) tizimli patologiyalarga qarshi kurashish uchun hujayraviy usullarni ishlab chiqish maqsadida yetakchi ekspertlarni birlashtiradi. Biomateriallar transportining xavfsizligi maxsus yetkazib berish kanallari orqali qat'iy vaqtlar bilan ta'minlanadi. Biznes immun dorilar va innovatsion terapiya ishlab chiqishga tayanadi. Joriy P/E koeffitsiyenti 0.00 ni tashkil etadi va quyidagi grafikdagi narxlar tarixi kompaniya aksiyalarining bozor dinamikasini aniq ko'rsatadi.

Prognoz qilingan narxning foydaga nisbati: Kyverna Therapeutics, Inc. (KYTX) 21.02.2024 - 17.11.2026 uchun

Kyverna Therapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahliliyoti:kyvernatx.com
Kyverna Therapeutics tovar namunasi

Forward P/E kutilayotgan foydaning bir birligi narxini belgilaydi va kapitalizatsiyaga nisbatan bozor kutuvlarini aks ettiradi. Ushbu ko'rsatkich aksiyaning joriy narxining prognoz qilingan bir aksiya uchun foydaga nisbati sifatida hisoblanadi. Biznesning forward P/E ko'rsatkichini tahlil qilish orqali investor potentsial o'sish uchun to'lanadigan premium miqdorini baholaydi. Kyverna Therapeutics (KYTX) uchun ushbu parametr juda muhimdir, chunki kompaniya kapitalni hujayra immunoterapiyasiga yo'naltirmoqda. Ushbu grafik bozor hozirda ushbu investitsiyalarning samaradorligini qanday baholayotganini aks ettiradi.

Kyverna Therapeutics (KYTX) raqobatchilari

Prognoz qilingan narxning foydaga nisbati ARGX (Argenx)|BNTX (BioNTech Group) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori ABVX (Abivax SA)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati admabiologics.com (ADMA)|PTGX - Kelajakdagi narxning foydaga nisbati|Immunovant Inc (IMVT) - Prognoz qilingan narxning foydaga nisbati|Kiniksa Corp (KNSA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Grifols, S.A.|Prognoz qilingan narxning foydaga nisbati ADPT|Forvard P/E multiplikatori celldex.com|Kelajakdagi narxning foydaga nisbati Aurinia Pharma (AUPH)|BioCryst Pharmaceuticals - Narxning kelajakdagi foydaga nisbati|Forvard P/E multiplikatori VERA (veratx.com)|Dianthus Pharma (DNTH) - Prognoz qilingan narx-foyda nisbati|PHVS - Kelajakdagi narxning foydaga nisbati|ABCL - Forvard P/E multiplikatori|Tourmaline (TRML) - Kelajakdagi narxning foydaga nisbati|Precigen - Kelajakdagi narx-foyda multiplikatori|PHAR (Pharming Group NV) - Forvard P/E multiplikatori|Forvard P/E multiplikatori Nektar Therapeutics|Kelajakdagi narxning foydaga nisbati Upstream Bio Inc (UPB)|Forvard P/E multiplikatori zenasbio.com (ZBIO)|Kelajakdagi narxning foydaga nisbati Immunome Corp IMNM|Forvard P/E multiplikatori Gossamer Bio Inc GOSS|KALV - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Prognoz qilingan narxning foydaga nisbati|Savara Inc. - Kelajakdagi narx-foyda multiplikatori|RIGL (Rigel Pharmaceuticals, Inc.) - Forvard P/E multiplikatori|Kelajakdagi narxning foydaga nisbati ANAB|Forvard P/E multiplikatori ATXS|ENGN - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori RAPT (rapt.com)|Kapitalizatsiyaning kelajakdagi foydaga nisbati JBIO (Aerovate)|Aclaris Therapeutics, Inc - Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati TLSA|CABA: Forvard P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Ventyx Bio|Kelajakdagi narxning foydaga nisbati Theratechnologies, Inc.|Prognoz qilingan narx-foyda nisbati Avalo Therapeutics AVTX|Forvard P/E multiplikatori ELDN|AGEN (Agenus, Inc.) - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Climb Bio, Inc. CLYM|Zura Bio Limited (ZURA) - Prognoz qilingan narx-foyda nisbati|ATYR: Prognoz qilingan narxning foydaga nisbati|adagene.com (ADAG) - Prognoz qilingan narxning foydaga nisbati|Ikena Oncology (IMA) - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Shattuck Labs, Inc.|Kelajakdagi narxning foydaga nisbati equilliumbio.com|Prognoz qilingan narxning foydaga nisbati connectbiopharm.com (CNTB)|Forvard P/E multiplikatori IMUX|Kapitalizatsiyaning prognoz qilingan foydaga nisbati Atara Bio|Kelajakdagi narxning foydaga nisbati InflaRx N.V. IFRX|X4 Pharmaceuticals - Kelajakdagi narxning foydaga nisbati|ACET: Prognoz qilingan narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori CELU (celularity.com)|INMB: Forvard P/E multiplikatori|BRNS: Kapitalizatsiyaning kelajakdagi foydaga nisbati|KZR (Kezar Life Sciences, Inc.) - Forvard P/E multiplikatori|SAB Biotherapeutics Inc. (SABS) - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Forvard P/E multiplikatori AKTX|Kelajakdagi narxning foydaga nisbati ENLV (Enlivex Therapeutics Ltd)|Kelajakdagi narxning foydaga nisbati Q32 Bio Inc. QTTB|GOVX - Prognoz qilingan narxning foydaga nisbati|EDSA - Kelajakdagi narxning foydaga nisbati|Prognoz qilingan narx-foyda nisbati iBio|CARM: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati XTLB (XTL Biopharmaceuticals, Ltd.)|Kelajakdagi narxning foydaga nisbati boltbio.com|Forvard P/E multiplikatori HCW Biologics|Forvard P/E multiplikatori APVO|AIM - Prognoz qilingan narx-foyda nisbati|Forvard P/E multiplikatori ADTX (Aditxt Inc.)|Kapitalizatsiyaning prognoz qilingan foydaga nisbati GRI Bio, Inc. (GRI)|XRTX - Kelajakdagi narxning foydaga nisbati|reshapelifesciences.com (HIND) - Prognoz qilingan narxning foydaga nisbati|REVB: Forvard P/E multiplikatori|Indaptus Therapeutics, Inc. - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Scinai|Prognoz qilingan narx-foyda nisbati CalciMedica, Inc. CALI|Kelajakdagi narxning foydaga nisbati Affimed NV (AFMD)|Forvard P/E multiplikatori Allakos Inc (ALLK)|Kelajakdagi narxning foydaga nisbati hookipapharma.com HOOK|Forvard P/E multiplikatori IGM Biosciences, Inc. IGMS|iTeos Pharma - Forvard P/E multiplikatori|OCEA - Forvard P/E multiplikatori|TCBP: Forvard P/E multiplikatori|Third Harmonic Bio - Kelajakdagi narx-foyda multiplikatori